William P. Sheridan
2016
In 2016, William P. Sheridan earned a total compensation of $818.1K as Senior Vice President and Chief Medical Officer at BioCryst Pharmaceuticals, a 48% decrease compared to previous year.
Compensation breakdown
| Option Awards | $324,040 |
|---|---|
| Salary | $457,700 |
| Other | $36,409 |
| Total | $818,149 |
Sheridan received $457.7K in salary, accounting for 56% of the total pay in 2016.
Sheridan also received $324K in option awards and $36.4K in other compensation.
Rankings
In 2016, William P. Sheridan's compensation ranked 9,197th out of 14,075 executives tracked by ExecPay. In other words, Sheridan earned more than 34.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,197 out of 14,075 | 35th |
Division Manufacturing | 3,551 out of 5,489 | 35th |
Major group Chemicals And Allied Products | 1,225 out of 1,895 | 35th |
Industry group Drugs | 971 out of 1,538 | 37th |
Industry Biological Products, Except Diagnostic Substances | 166 out of 279 | 41st |
Source: SEC filing on April 12, 2017.
Sheridan's colleagues
We found four more compensation records of executives who worked with William P. Sheridan at BioCryst Pharmaceuticals in 2016.
2016
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
2016
Thomas Staab
BioCryst Pharmaceuticals
Chief Financial Officer
2016
Lynne Powell
BioCryst Pharmaceuticals
Senior Vice President and Chief Commercial Officer
2016
Yarlagadda Babu
BioCryst Pharmaceuticals